Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
869 NBTXR3-enhanced proton beam immunoradiotherapy reshapes tumor immune microenvironment and improves abscopal effect in an anti-PD1-resistant lung cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.